Old Web
English
Sign In
Acemap
>
Paper
>
O-011 Azacitidine (AZA) + idarubicin (IDA) in untreated high-risk MDS – A GFM phase I/II study
O-011 Azacitidine (AZA) + idarubicin (IDA) in untreated high-risk MDS – A GFM phase I/II study
2013
L. Ades
B. de Renzis
Ramzi Jeddi
Jacques Delaunay
Thorsten Braun
Mathilde Hunault-Berger
A. Stamatoullas
Laurence Sanhes
Benedicte Samey
Fatiha Chermat
Balkis Meddeb
P. Fenaux
Keywords:
Cancer research
Immunology
Idarubicin
Azacitidine
Biology
phase i ii
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]